Iridex (IRIX) Free Cash Flow Growth (1y) (2012 - 2026)
Iridex (IRIX) Free Cash Flow Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 28.87% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 14.12% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 13.29% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 142.84% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | -11.68% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 750.00% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 0.40% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | -14.34% |
| 10 | Iridex | 13.32 Mn | 8.64 Mn | 4.30 Mn | 133.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -36.37% |
| Jan 3, 2026 | 165.07% |
| Sep 27, 2025 | 54.96% |
| Jun 28, 2025 | 72.40% |
| Mar 29, 2025 | 36.22% |
| Dec 28, 2024 | -16.79% |
| Sep 28, 2024 | -49.85% |
| Jun 29, 2024 | -16.51% |
| Mar 30, 2024 | 42.79% |
| Dec 30, 2023 | 30.52% |
| Sep 30, 2023 | 30.70% |
| Jul 1, 2023 | 60.30% |
| Apr 1, 2023 | 11.99% |
| Dec 31, 2022 | -115.29% |
| Apr 2, 2022 | -127.59% |
| Apr 3, 2021 | 924.06% |
| Sep 26, 2020 | 118.36% |
| Jun 27, 2020 | -51.53% |
| Mar 28, 2020 | 61.93% |
| Dec 28, 2019 | 92.06% |